The Clinical Core is a pivotal complement of the proposed ADCC. This Core will serve as resource for University investigators in need of specific populations of AD patients and controls.
Specific Aim 1 will make available to institutional researchers well characterized AD patients. All patients initially recruited will only be mildly demented (i.e., Mini- Mental State Scores > 20), will have all other treatable and nontreatable forms of dementia other than AD eliminated by careful evaluation, and will undergo consensus diagnosis. Fifty patients per year will be recruited with annual longitudinal evaluation planned.
Specific Aim 2 will further define the behavioral disturbances associated with AD, by longitudinally evaluating those patients recruited in Specific Aim 1 and recruiting a group of severely disturbed AD patients residing in our state mental hospital.
Specific Aim 3 will make available to institutional researchers a well characterized group of elderly normal Black individuals (i.e., 25/year).
Specific Aim 4 will document clinical diagnoses and assist in acquiring tissue for the Neuropathology Core by attempting to obtain autopsies on all patients followed in the Clinical Core.
Specific Aim 5 will provide data management and biostatistical services. A central data file will be developed on all patients and maintained on computer so that patient status and participation in research projects can be ascertained. Biostatistical services will also be provided to all ADCC investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG010163-05S1
Application #
6234322
Study Section
Project Start
1997-09-30
Project End
1998-06-30
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Bambara, Jennifer K; Griffith, H Randall; Martin, Roy C et al. (2007) Medical decision-making abilities in older adults with chronic partial epilepsy. Epilepsy Behav 10:63-8
Griffith, H R; Dymek, M P; Atchison, P et al. (2005) Medical decision-making in neurodegenerative disease: mild AD and PD with cognitive impairment. Neurology 65:483-5
Marson, D C (2001) Loss of competency in Alzheimer's disease: conceptual and psychometric approaches. Int J Law Psychiatry 24:267-83
Dymek, M P; Atchison, P; Harrell, L et al. (2001) Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease. Neurology 56:17-24
Marson, D C; Earnst, K S; Jamil, F et al. (2000) Consistency of physicians' legal standard and personal judgments of competency in patients with Alzheimer's disease. J Am Geriatr Soc 48:911-8
Earnst, K S; Marson, D C; Harrell, L E (2000) Cognitive models of physicians' legal standard and personal judgments of competency in patients with Alzheimer's disease. J Am Geriatr Soc 48:919-27
Marson, D; Harrell, L (1999) Executive dysfunction and loss of capacity to consent to medical treatment in patients with Alzheimer's disease. Semin Clin Neuropsychiatry 4:41-9
Marson, D C; Annis, S M; McInturff, B et al. (1999) Error behaviors associated with loss of competency in Alzheimer's disease. Neurology 53:1983-92
Marson, D C; McInturff, B; Hawkins, L et al. (1997) Consistency of physician judgments of capacity to consent in mild Alzheimer's disease. J Am Geriatr Soc 45:453-7
Deutsch, G; Mountz, J M; Katholi, C R et al. (1997) Regional stability of cerebral blood flow measured by repeated technetium-99m-HMPAO SPECT: implications for the study of state-dependent change. J Nucl Med 38:6-13

Showing the most recent 10 out of 24 publications